NeueHealth, Inc. (NYSE:NEUE - Get Free Report) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 21,300 shares, a decrease of 49.5% from the April 15th total of 42,200 shares. Based on an average trading volume of 11,700 shares, the days-to-cover ratio is presently 1.8 days.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada increased their target price on shares of NeueHealth from $7.00 to $8.00 and gave the stock a "sector perform" rating in a research report on Wednesday, March 13th.
Check Out Our Latest Stock Report on NeueHealth
Insider Activity
In related news, CEO George Lawrence Mikan III sold 7,886 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $9.88, for a total transaction of $77,913.68. Following the transaction, the chief executive officer now owns 88,483 shares of the company's stock, valued at $874,212.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders sold 28,100 shares of company stock valued at $230,365. 64.30% of the stock is owned by company insiders.
NeueHealth Stock Up 1.8 %
NEUE traded up $0.11 during trading on Friday, hitting $6.16. The company's stock had a trading volume of 22,726 shares, compared to its average volume of 5,343. The company has a market capitalization of $50.64 million, a PE ratio of -0.05 and a beta of 0.78. The company's 50 day moving average price is $6.70. NeueHealth has a 12 month low of $4.94 and a 12 month high of $26.95.
NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings results on Wednesday, March 6th. The company reported $20.07 earnings per share (EPS) for the quarter. NeueHealth had a negative net margin of 89.78% and a negative return on equity of 6.14%. The business had revenue of $292.87 million for the quarter. As a group, analysts predict that NeueHealth will post -10.87 earnings per share for the current year.
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
